Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026)
Becton Dickinson's (BDX) quarterly Total Non-Current Liabilities came in at $23.9 billion in Q2 2026, down 10.07% year-over-year from $26.6 billion in Q2 2025, and down 1.31% quarter-over-quarter from $24.2 billion in Q1 2026.
Analysis
Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Total Non-Current Liabilities for 18 consecutive years, with $23.9 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 10.07% year-over-year to $23.9 billion in Q2 2026; TTM through Jun 2026 was $23.9 billion, a 10.07% decrease from a year earlier, with the FY2025 full-year figure at $27.3 billion, down 1.92% from the prior year.
- Total Non-Current Liabilities was $23.9 billion for Q2 2026 at Becton Dickinson, down from $24.2 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $27.8 billion in Q3 2024 and troughed at $22.4 billion in Q3 2023.
- A 5-year average of $24.7 billion and a median of $24.2 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities advanced 24.27% in 2024 and retreated 10.07% in 2026, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $22.8 billion in 2022, then declined by 1.17% to $22.5 billion in 2023, then grew by 15.6% to $26.0 billion in 2024, then rose by 2.7% to $26.7 billion in 2025, then fell by 10.56% to $23.9 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $23.9 billion (Q2 2026), $24.2 billion (Q1 2026), and $26.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 23.92 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 17.56 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 996.30 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 12.41 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -89.27 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 75.19 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 13.70 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 4.54 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 333,758.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.92 Bn |
| Mar 31, 2026 | 24.24 Bn |
| Dec 31, 2025 | 26.74 Bn |
| Sep 30, 2025 | 27.30 Bn |
| Jun 30, 2025 | 26.60 Bn |
| Mar 31, 2025 | 26.23 Bn |
| Dec 31, 2024 | 26.04 Bn |
| Sep 30, 2024 | 27.84 Bn |
| Jun 30, 2024 | 25.64 Bn |
| Mar 31, 2024 | 24.21 Bn |
| Dec 31, 2023 | 22.53 Bn |
| Sep 30, 2023 | 22.40 Bn |
| Jun 30, 2023 | 22.71 Bn |
| Mar 31, 2023 | 24.23 Bn |
| Dec 31, 2022 | 22.80 Bn |
| Sep 30, 2022 | 22.60 Bn |
| Jun 30, 2022 | 22.77 Bn |
| Mar 31, 2022 | 25.29 Bn |
| Dec 31, 2021 | 24.17 Bn |
| Sep 30, 2021 | 24.98 Bn |